Yahoo Sports’ 26-and-under power rankings are a remix on the traditional farm system rankings that assess the strength of MLB organizations’ talent base among rookie-eligible and MiLB players. While ...

AUSTIN, Texas, March 04, 2025--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that the U.S. Patent and Trademark Office has ...

A week ago, Natera, Inc. (NASDAQ:NTRA) came out with a strong set of yearly numbers that could potentially lead to a re-rate of the stock. Natera beat expectations with revenues of US$1.7b ...

BTIG analyst Mark Massaro maintained a Buy rating on Natera (NTRA – Research Report) today and set a price target of $190.00. The company’s shares closed yesterday at $142.35. See what stocks ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that the U.S. Patent and Trademark Office has issued Natera a new patent related to testing of ...

Feb 21 - Medical diagnostics company Guardant Health (GH.O), opens new tab has sued rival Natera (NTRA.O), opens new tab in California federal court for allegedly stealing trade secrets related to ...

Morgan Stanley analyst Tejas Savant raised the firm’s price target on Natera (NTRA) to $185 from $176 and keeps an Overweight rating on the shares. Q4 revenue came in a touch above the ...

Shares of Natera, Inc. (NASDAQ:NTRA – Get Free Report) saw strong trading volume on Tuesday after Morgan Stanley raised their price target on the stock from $176.00 to $185.00.Morgan Stanley ...

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will release results for its fourth quarter and year ...